Cart
sales@molnova.com
SC-202671
CAS No. 312917-14-9
SC-202671 ( TCS JNK 5a, TCS-JNK-5a, JNK Inhibitor IX, SC-202671 )
Catalog No. M18411 CAS No. 312917-14-9
TCS JNK 5a is an effective, specific inhibitor of JNK3(pIC50= 6.7), JNK2(pIC50=6.5).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 500MG | 655 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSC-202671
-
NoteResearch use only, not for human use.
-
Brief DescriptionTCS JNK 5a is an effective, specific inhibitor of JNK3(pIC50= 6.7), JNK2(pIC50=6.5).
-
DescriptionTCS JNK 5a, also called JNK Inhibitor IX , is a selective and potent inhibitor of JNK inhibitor. Exposure of human Jurkat T cells to SC-202671 targeting JNK2 and JNK3, caused apoptotic DNA fragmentation along with G2/M arrest, phosphorylation of Bcl-2, Mcl-1, and Bim, Δψm loss, and activation of Bak and caspase cascade.
-
SynonymsTCS JNK 5a, TCS-JNK-5a, JNK Inhibitor IX, SC-202671
-
PathwayOthers
-
TargetOther Targets
-
RecptorJNK2; JNK3
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number312917-14-9
-
Formula Weight332.42
-
Molecular FormulaC20H16N2OS
-
Purity98%
-
SolubilityDMSO : ≥ 51 mg/mL; 153.42 mM
-
SMILESC1CCc2c(C1)c(c(s2)NC(=O)c1cccc2ccccc12)C#N
-
Chemical NameN-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-1-naphthamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cotadutide acetate
Cotadutide acetate (MEDI0382 acetate) is a potent peptide?dual?agonist?of glucagon-like?peptide-1?(GLP-1) and?glucagon?receptor with EC50 values of 6.9 pM and 10.2 pM, respectively.
-
Fibrinopeptide A, hu...
Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.
-
SM-102
SM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.
